gated, the generation and development of seizures is not fully elucidated.
In the present study, we characterize the alterations of CaN activity, protein expression and phosphorylation of GABA A R in hippocampus after KA-induced SE. Western blot analysis demonstrated that a time-dependent increase in CaN activity and protein expression, and a down-regulation of GABA A R phosphorylation induced by SE. These changes were shown to have different responses to FK506, with attenuation of CaN activity and its protein expression and inhibition of GABA A R dephosphorylation. This raises the possibilities that CaN plays an important role in epileptogenesis via dephosphorylation of GABA A R, and that CaN inhibitor such as FK506 may have clinical potential in the treatment of refractory seizures.
Experimental procedures

Experimental animals
Adult male Wistar rats (Experimental Animal Center of Shandong University, China) weighing 180-270 g were used. Animals were maintained in a temperature-controlled room (26 8C) with a 12 h light/dark cycle and free access to food and water. The experimental procedures were approved by the Commission of Shandong University for the ethics of experiments on animals, in accordance with international standards. Seizures were scored using a modified Racine scale. 14 
Pre-treatment of animals
The animals were divided into five groups (25 rats in each group, n = 125): a control group (no pre-treatment, followed by saline, 0.9%); a KA group (no pre-treatment, followed by KA); a KA + saline group (saline pre-treatment, followed by KA after 0.5 h); an FK506 group (FK506 pre-treatment, followed by KA after 0.5 h); and a rapamycin group (rapamycin pre-treatment, followed by KA after 0.5 h). The CaN inhibitor, FK506 (Fujisawa, Japan) was administered as a single i.p. bolus at 2 mg/kg bw; and the immunosuppressant (but not CaN inhibitor) rapamycin (Sigma) was administered as a single i.p. bolus at 10 mg/kg bw.
Induction of status epilepticus
Seizures were induced by intracerebroventricular injection of KA (Sigma, USA). Briefly, rats were anaesthetized with intraperitoneal (i.p.) pentobarbital (50 mg/kg, Sigma) and were placed in a stereotaxic frame. Then 0.5 mg of KA dissolved in 1.0 ml of 0.9% NaCl was injected by microsyringe following the stereotaxic coordinates: 0.85 mm caudal, 1.5 mm lateral, and 4.3 mm deep, relative to the bregma. Only rats with sustained generalized motor seizures that scored 4-5 on the Racine scale were included in the experimental groups. Seizures were allowed to continue for 30 min and were terminated by an injection of diazepam (i.p., 10 mg/kg, Sigma). The proportions of animals having stage 4 and 5 seizures were 92%, 88%, 84%, and 88% in the KA, KA + saline, FK506, and rapamycin groups, respectively (p > 0.05).
Sample preparation
Four animals from each group were decapitated at 2, 6, 12, 24 and 72 h after SE induction to analyze for CaN activity, CaN protein expression and GABA A R dephosphorylation. Brains were dissected in Petri dishes on ice in order to preserve postmortem enzyme activity. Hippocampus was isolated and immediately homogenized in ice-cold homogenization buffer containing 5 mM HEPES (pH 7.0), 7 mM EGTA, 5 mM EDTA, 1 mM dithiothreitol (DTT), 0.3 mM phenylmethyl sulfonyl fluoride (PMSF), and 300 mM sucrose. The samples were then centrifuged at 12,000 rpm for 10 min at 4 8C, and stored at À80 8C.
CaN activity assay
CaN activity was assayed using the procedure detailed by Kurz et al. 12 All reaction tubes were prepared on ice and contained the following: 25 mM morpholinopropanesulfonic acid, pH 7.0, 1 mM DTT, 2 mM p-nitrophenol phosphate (pNPP), and 150 nM okadaic acid. Basal tubes also contained 2 mM EGTA and 2 mM EDTA, while the treated tubes contained 2 mM MnCl 2 . Mn 2+ activates
CaN more strongly than Ca 2+ , 15 and Mn 2+ was therefore used in the maximal reactions in order to maximize the cation-stimulated activity of the enzyme. Reactions were incubated at 37 8C for 30 min in a shaking water bath. Prior to use, protein concentration of all homogenates was determined using the method of Bradford. 16 Tubes were then removed from the water bath and placed on ice to stop the reaction. The absorbance of the reaction mixture was immediately measured at 405 nm in a plate reader, and absorbance units were converted to mg/ml of PNP (pnitrophenol) produced by comparison with a pNP concentration standard absorption curve.
Immunoblotting
Forty micrograms of protein was separated by sodium dodecyl sulfate-polyacrylamide (SDS) gel electrophoresis and then transferred into nitrocellulose membranes. After blocking in 5% fat-free milk for 1 h, the membranes were incubated with primary antibodies to CaN (1:13,000, Sigma), and GABA A R 2/3 (1:500, Boehringer Mannheim, Germany) at 4 8C overnight. They were then incubated with horseradish peroxidase-conjugated second antibodies (1:3000, Santa Cruz Biotechnology, CA, USA) for 1 h. Immunoreactivity was enhanced using a chemiluminescence kit (Pierce, Rockford, IL, USA) and preparations were exposed to film. The bands were scanned and analyzed using an image analyzer (Alpha Innotech, San Leandro, CA, USA).
Data analysis
The data are shown as the means AE SEM. Statistical analysis was performed using one-way ANOVA followed by Newman-Keuls test with SPSS 12.0 (SPSS Inc., USA). The proportion of animals with stage 4 and 5 seizures was analyzed by x 2 test. Statistical significance was accepted at the conventional p < 0.05 level.
Results
Behavioral episodes
Behavioral episodes induced by KA followed the typical course of seizures, with a gradual increase in intensity to SE. No differences in behavioral seizures were noted in these rats pretreated with or without FK506. Control animals did not exhibit any behavioral seizure activity.
Characteristics of CaN activity in rats with KA-induced SE
To determine if CaN levels were elevated after KA-induced SE, we measured CaN activity at 2, 6, 12, 24 and 72 h after SE. The results showed that a significant increase in both basal and maximal CaN activity was seen after SE, with a peak at 2 h (p < 0.01), and a return to basal levels after 24 h (Fig. 1A) . We also observed that pre-treatment with FK506 remarkably decreased the SE-induced CaN activity at 2 h (p < 0.01) (Fig. 1A  0 ) . It is therefore suggested that the CaN activity induced by SE is time-dependent, and also is inhibited by FK506.
Characteristics of CaN protein expression in KA-induced SE
In order to determine whether the observed increase in CaN activity induced by SE was associated with the CaN protein expression, the total CaN protein levels in hippocampus at 2, 6, 12, 24 and 72 h after SE were measured by using Western blot analysis. As shown in Fig. 2A and A 0 , immunoblots indicated that a significant increase in CaN protein expression was observed at 24 h after SE (p < 0.05), and still remained until 72 h (p < 0.01). Taking together with the SE-induced CaN activity in time course, it is suggested that the SE-induced increase in CaN activity does not depend on CaN protein expression. In addition, pre-treatment with FK506 has been shown to result in inhibition of CaN protein expression at 72 h after SE (p < 0.05) (Fig. 3A and A 0 ), demonstrating that FK506 can inhibit not only CaN activity but also CaN protein expression induced by SE.
Dephosphorylation of GABA A R 2/3 subunits induced by SE
We measured phosphorylation state of GABA A R 2/3 subunits at 2, 6, 12, 24 and 72 h after SE induction using anti-phosphoserine/ threonine antibodies against immunoprecipitated GABA A R 2/3 subunit protein. At 2, 6, 12 and 24 h after SE, the level of phosphorylation of serine/threonine residues in GABA A R 2/3 subunits was significantly decreased (p < 0.01, p < 0.01, p < 0.05, p < 0.05, respectively), with no alteration in total 2/3 subunit protein (p > 0.05) (Fig. 4A and A  0 ) . We also investigated the association between FK506 and the phosphorylation state of GABA A R 2/3 subunits after SE induction. FK506 significantly increased the level of phosphorylation of serine/threonine residues at 2 h after SE (p < 0.05) (Fig. 5A and A 0 ). 
FK506-mediated GABA A R dephosphorylation by inhibition of CaN
To determine if the effects of FK506 on GABA A R dephosphorylation could have been caused by actions other than CaN inhibition, we examined the effects of immunosuppressant rapamycin (Sigma, 10 mg/kg, i.p.). Rapamycin is a derivative of FK506 that also binds to the immunophilin FKBP12, but, unlike FK506, the FKBP12-rapamcyin complex does not inhibit CaN activity. 17 Compared with KA group, no significant changes in GABA A R dephosphorylation were observed after rapamycin administration ( Fig. 5A and A  0 ). This suggests that the effects of FK506 on GABA A R dephosphorylation were mediated by its ability to inhibit CaN activity.
Discussion
In our study, we found that KA-induced seizures resulted in a rapid increase in basal and maximal CaN activity and a delayed CaN protein expression. This lead us to speculate that a acute increase in CaN activity after SE was not due to a rapid increase in CaN protein expression, but rather to an increase in CaN activation state or kinetics. These results are supported by the study in adult SE models. 18 There are several possible mechanisms that could account for the increase in CaN activity. As a calcium/calmodulin-stimulated enzyme, CaN can be stimulated by increased intracellular Ca 2+ concentrations. 19 After SE, the function of Mg 2+ /Ca 2+ ATPase that regulates intracellular Ca 2+ concentrations is lost, 20, 21 and ATPasemediated uptake of Ca 2+ into the microsomes is also less efficient, 20 which could potentially result in higher than normal resting intracellular Ca 2+ concentrations. 3 The increased intracellular Ca 2+ associated with SE could be responsible for activating CaN above its normal physiological level.
On the other hand, the increase in CaN activity may be related to the activation of inflammatory induced by SE. An increasing body of evidence demonstrates that seizure activates inflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor (TNF-a) and the related pro-and anti-inflammatory genes in glia. 22, 23 These inflammatory cytokines may contribute to altered neuronal network excitability and consequently affect the down-stream events involved in epileptogenesis and pathologic changes. 24 Therefore, CaN activity could not only regulate inflammatory cytokines but also be triggered by pro-inflammatory cytokines such as IL-1b and TNF-a. 25 Additionally, the increase in CaN activity may be associated with an opening of the blood-brain-barrier (BBB). The BBB disruption and opening are shown in epileptic rats and humans, both shortly after SE as well as in the chronic epileptic phase. 26 Changes in BBB integrity may be caused by increase local blood pressure that occurs during seizure, 27 free radical formation, 28 and inflammation responses. 22 BBB leakage may contribute to the increased excitability and development of calcium waves in astrocyte, 26 which activate NMDA receptors through feed-forward synaptic activation. CaN activation is modulated via NMDA channel-mediated calcium influx.
12
GABA A R is the primary receptor responsible for the fast inhibitory response in neuronal tissue, and plays a major role in preventing the neuronal hyperexcitability associated with epilepsy and SE. The serine/threonine residues within the GABA A R 2/ 3 subunits are key residues for modulating GABA A R function, 29 and dephosphorylation by CaN can decrease GABA A R-mediated responses to GABA 30 and cell surface GABA A R stability. 31 In this study, we showed that a decrease in serine/threonine phosphorylation of GABA A R at 2-12 h after SE induction was coincident with an increase in CaN activity. These findings suggest that GABA A Rs are likely targets of CaN-mediated dephosphorylation, and that the longer term production of chronic epilepsy are attributable, at least in part, to GABA A R dephosphorylation. A previous study also demonstrated that CaN activation resulted in down-regulation of synaptic GABAergic inhibition. 32 Although the dephosphorylation of serine/threonine within the GABA A 2/3 subunit may be mediated by multiple mechanisms, our results suggest that CaN plays a role in this modulation. The increase in CaN protein expression at 24 h post-SE may be related to the decrease in serine/threonine phosphorylation of the GABA A R at 24 h after SE, which causes development of chronic refractory seizures. However, upon the increase in CaN protein expression, no change in GABAAR phosphorylation at 72 h after SE induction may be correlated with other mechanisms, which need to be further studied. Similar to the reported by Sanchez et al., 13 FK506 was shown to inhibit CaN activity, CaN protein expression and GABA A R dephosphorylation in our study. Additionally, we also investigated the effects of the immunosuppressant rapamycin in order to establish if the effects of FK506 on GABA A R dephosphorylation could have been caused by actions other than CaN inhibition. Rapamycin is a derivative of FK506 that also binds to the immunophilin FKBP12. However, unlike FK506, the FKBP12-rapamcyin complex does not inhibit CaN activity. 10 In our current model, we found that application of rapamycin had no significant effect on GABA A R dephosphorylation after KAinduced seizures. Despite FK506 could reverse CaN-mediated dephosphorylation of GABA A R, FK506 did not prevent seizures in our study. We speculate that loss of GABA A R integrity is involved in kindling as a delayed mechanism able to reduce the seizure threshold.
Overall, CaN plays a pivotal/important role in SE induction via mediation of GABA A R dephosphorylation. FK506 has the potential to acutely decrease hippocampal excitability and disrupt longterm epileptogenesis. It is therefore believed that CaN inhibitor has clinical potential for the treatment of chronic refractory seizures.
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